Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-14

Clinical Trial Update: TSA-DC Vaccine in Treating Patients With Gastrointestinal Solid Tumor [NA]

View source ↗

Summary

This is a clinical trial update about the TSA-DC Vaccine for gastrointestinal solid tumors. The current status is unknown and no results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TSA-DC Vaccine

Snippet

Sponsor: BGI, China | Conditions: Tumor Gastric, Tumor, Colorectal | NA | Status: UNKNOWN